Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variant JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study

enthalten in: bioRxiv.org | 2024

von de Prost, N. | Audureau, E. | Guillon, A. | +22

Inflammatory proteins as strong predictors of death in COVID-19 patients with coexisting neurological diseases

enthalten in: bioRxiv.org | 2024

von Zielińska-Turek, J. | Turek, G. | Lyson, T. | +3

Cohort profile: a multicenter European study of acute respiratory infections: the MERMAIDS-ARI 2.0 cohort study

enthalten in: bioRxiv.org | 2024

von de Hoog, M. | Prat-Aymerich, C. | Troeman, D. | +7

Anti-inflammatory therapy with nebulised dornase alfa for severe COVID-19 pneumonia

enthalten in: bioRxiv.org | 2024

von Porter, J. | Inshaw, J. | Solis, V. | +22

Revisit the Inhibitory Effects of Glucocorticoids on Immunocytes

enthalten in: bioRxiv.org | 2024

von Wu, S. | Zhao, S. | Zhong, Y. | +1

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

enthalten in: bioRxiv.org | 2023

von Horby, P. | Emberson, J. | Mafham, M. | +30

CCR5/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in murine model of the SARS-CoV-2-related acute respiratory distress syndrome

enthalten in: bioRxiv.org | 2023

von Chernov, A. | Rodionov, M. | Kazakov, V. | +6

Mycobiome analyses of critically ill COVID-19 patients

enthalten in: bioRxiv.org | 2023

von Weaver, D. | Gago, S. | Bassetti, M. | +8

One year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study

enthalten in: bioRxiv.org | 2023

von Leavy, O. | Russell, R. | Harrison, E. | +70

SARS-CoV-2-specific Humoral and Cell-mediated Immune Responses after Immunization with Inactivated COVID-19 Vaccine in Kidney Transplant Recipients (CVIM 1 Study)

enthalten in: bioRxiv.org | 2023

von Bruminhent, J. | Sethaudom, C. | Chaumdee, P. | +10